• OPEN AN ACCOUNT
Indian Indices
Sensex
73,598.67 -8.08
( -0.01%)
Global Indices
Nasdaq
52,379.88 143.72
(0.28%)
Dow Jones
7,698.05 53.37
(0.70%)
Hang Seng
63,411.54 1,221.89
(1.96%)
Nikkei 225
10,685.39 -81.94
(-0.76%)
Forex
USD-INR
94.93 0.33
(0.34%)
EUR-INR
106.36 0.18
(0.17%)
GBP-INR
126.93 0.23
(0.18%)
JPY-INR
0.61 0.00
(0.53%)

EQUITY - MARKET SCREENER

Ishita Drugs & Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524400
INE806D01016
38.6883488
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
29.89
21.09
EPS(TTM)
Face Value()
Div & Yield %
2.36
10
0
 

Maharashtra Seamless Q1 PAT jumps 16% YoY to Rs 266 cr
Aug 07,2026

However, total revenue declined 4.72% year on year (YoY) to Rs 1,091.20 crore in Q1 FY27.

Profit before tax stood at Rs 322.41 crore in Q1 FY27, up 7.59% as against Rs 299.65 crore in Q1 FY26.

Total expenses decreased 6.25% YoY to Rs 939.49 crore. Employee benefits expense rose 12.99% to Rs 36.61 crore, while other expenses were higher by 5.31% at Rs 238.33 crore in Q1 FY27.

The company has appointed Shiv Kumar Singhal as Whole-time Director, effective 7 August 2026, for a period of three years, subject to shareholders’ approval.

Maharashtra Seamless manufactures carbon and alloy steel seamless pipes, ERW steel pipes, and casting pipes. The company also operates a windmill.

The scrip added 1.19% to end at Rs 590.05 on the BSE.